ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs MXN
17.12235
0.64%
Brent Oil
86.015
-1.46%
Bitcoin
59,913.12
-6.13%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Rocket Pharmaceuticals Inc (RCKT)

  7. Rocket Pharmaceuticals Inc (RCKT) Noticias

RCKT Rocket Pharmaceuticals Inc

21.67
-0.18 (-0.82%)
Última actualización: 14:55:05
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Rocket Pharmaceuticals Inc RCKT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.18 -0.82% 21.67 14:55:05
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
21.57 21.44 22.18 21.85
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
02/4/202405:00BWRocket Pharmaceuticals Announces European Medicines Agency..
26/3/202415:01BWRocket Pharmaceuticals Announces Appointment of Aaron Ondrey..
04/3/202417:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202417:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202414:54EDGAR2Form 144 - Report of proposed sale of securities
29/2/202413:59EDGAR2Form 144 - Report of proposed sale of securities
26/2/202415:37EDGAR2Form 8-K - Current report
26/2/202415:01BWRocket Pharmaceuticals Reports Fourth Quarter and Full Year..
21/2/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202419:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202416:28EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
16/2/202415:37EDGAR2Form 144 - Report of proposed sale of securities
16/2/202415:31EDGAR2Form 144 - Report of proposed sale of securities
16/2/202415:26EDGAR2Form 144 - Report of proposed sale of securities
16/2/202415:22EDGAR2Form 144 - Report of proposed sale of securities
16/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202415:37EDGAR2Form 8-K - Current report
13/2/202406:00BWRocket Pharmaceuticals Announces Update on FDA Review..
29/1/202414:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202415:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202414:16EDGAR2Form 144 - Report of proposed sale of securities
02/1/202415:01BWRocket Pharmaceuticals to Present at 42nd Annual J.P. Morgan..
13/12/202315:05EDGAR2Form 8-K - Current report
12/12/202319:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202319:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/12/202306:00BWRocket Pharmaceuticals Appoints R. Keith Woods to Board of..
16/11/202318:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202318:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202318:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202317:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202314:28EDGAR2Form 144 - Report of proposed sale of securities
16/11/202314:21EDGAR2Form 144 - Report of proposed sale of securities
16/11/202314:21EDGAR2Form 144 - Report of proposed sale of securities
07/11/202315:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202315:04BWRocket Pharmaceuticals Reports Third Quarter 2023 Financial..
25/10/202308:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202314:19EDGAR2Form 144 - Report of proposed sale of securities
19/10/202306:00BWRocket Pharmaceuticals Announces Presentations Highlighting..
10/10/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202320:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202315:05EDGAR2Form 8-K - Current report
02/10/202306:00BWRocket Pharmaceuticals Announces FDA Acceptance of Biologics..
26/9/202315:01BWRocket Pharmaceuticals to Participate in the Chardan 7th..
20/9/202315:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]

Su Consulta Reciente

NASDAQ
RCKT
Rocket Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados